X4 Pharmaceuticals reported cash from operations of -$20.80M and free cash flow of -$20.80M for the quarter ended Jun 2026, up 30.4% year over year. This cash flow statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||||
| Net Income | -20.18M | -30.21M | -21.96M | -21.21M | -21.59M | -29.10M | -24.02M | -55.71M | -2.31M | -19.13M | -51.77M | 90.83M | -36.70M | -39.82M | 0.28M | -25.74M | -29.82M | -23.93M | -20.24M | -16.16M | ||||||||||||||||||
| Share-based CompensationStock Comp. | 1.52M | 1.61M | 1.46M | 1.52M | 1.11M | 1.11M | 1.65M | 2.14M | 2.36M | 2.54M | 1.74M | 2.43M | 1.82M | 2.22M | 0.52M | 0.75M | 0.76M | 2.27M | 2.41M | 3.09M | ||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | -5.44M | 29.86M | -25.16M | 13.76M | -20.21M | 1.86M | ||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -14.21M | -19.05M | -20.23M | -18.47M | -19.31M | -19.09M | -26.51M | -47.90M | -68.80M | -27.75M | -33.60M | -63.90M | -34.03M | -32.99M | -12.37M | -29.90M | -27.83M | -15.52M | -19.60M | -20.80M | ||||||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.13M | 0.13M | 0.13M | 0.13M | 0.12M | 0.12M | 0.13M | 0.13M | 0.10M | 0.06M | 0.06M | 0.19M | 0.27M | 0.27M | 0.48M | 0.35M | 0.22M | 0.22M | 0.22M | 1.00M | ||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 1.07M | -0.56M | 0.64M | -0.25M | -0.32M | 0.54M | 0.93M | |||||||||||||||||||||||||||||||
| Change in InventoryChange Inventory | 0.83M | 1.61M | 0.37M | 0.27M | 0.08M | 0.91M | 0.40M | 0.16M | 0.86M | |||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | -0.10M | 1.86M | -0.71M | 0.11M | 0.12M | 3.91M | -1.71M | -1.10M | 3.24M | 0.81M | 0.00M | -0.95M | 0.58M | 0.08M | 2.48M | -3.44M | -2.65M | 0.64M | -0.62M | -1.14M | ||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 1.92M | -1.22M | -0.98M | 1.64M | 0.65M | 2.50M | 0.50M | 4.53M | 0.63M | -4.04M | 1.26M | 2.74M | -0.17M | 3.34M | -7.78M | 0.23M | 3.37M | 2.17M | -1.55M | -2.93M | ||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | 1.81M | -0.23M | -0.20M | -0.30M | -0.06M | 0.41M | ||||||||||||||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.02M | 0.01M | 0.02M | 0.04M | 0.01M | 0.03M | 0.01M | 0.01M | 0.01M | 0.04M | 0.06M | 3.44M | 0.50M | |||||||||||||||||||||||||
| Change in IntangiblesChange Intangibless | ||||||||||||||||||||||||||||||||||||||
| Acquisitions | ||||||||||||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 1.00M | 1.00M | 5.00M | 2.00M | 5.25M | 14.20M | 11.75M | 28.18M | 15.87M | 18.75M | 19.25M | 4.00M | ||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.02M | -0.01M | -0.02M | -0.04M | -0.01M | -0.03M | -0.01M | -4.88M | -5.16M | -4.83M | -5.32M | 96.86M | -15.93M | -8.62M | -3.14M | 23.11M | -28.67M | 16.85M | 19.25M | -1.00M | ||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.14M | 0.05M | 0.05M | 0.00M | 0.07M | |||||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -4.44M | 24.57M | 4.96M | -0.35M | 51.98M | 60.64M | -2.12M | 69.34M | 21.20M | 0.10M | 20.16M | 0.14M | 5.63M | 86.91M | 146.09M | 0.00M | 0.07M | |||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | ||||||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.00M | 51.38M | 86.91M | 146.04M | ||||||||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.10M | -0.12M | -0.07M | -0.20M | -0.20M | 0.36M | 0.05M | -0.01M | -0.07M | 0.13M | -0.06M | -0.02M | 0.17M | -0.24M | 0.07M | 0.14M | -0.00M | 0.00M | -0.02M | -0.01M | ||||||||||||||||||
| Change in Cash | -18.77M | 5.39M | -15.36M | -19.06M | 32.47M | 41.88M | -28.59M | 43.02M | -4.85M | -32.36M | -38.98M | 86.73M | -49.80M | -41.73M | -15.43M | -1.02M | 30.41M | 147.42M | -0.36M | -21.72M | ||||||||||||||||||
| Free Cash FlowFCF | -14.23M | -19.07M | -20.25M | -18.51M | -19.32M | -19.13M | -26.52M | -47.91M | -68.81M | -27.78M | -33.66M | -67.34M | -34.03M | -32.99M | -12.37M | -29.90M | -27.83M | -16.02M | -19.60M | -20.80M | ||||||||||||||||||
| Net Cash FlowNCF | -18.67M | 5.50M | -15.29M | -18.86M | 32.66M | 41.52M | -28.64M | 16.55M | -52.75M | -32.48M | -38.92M | 53.12M | -49.96M | -41.48M | -15.51M | -1.16M | 30.41M | 147.42M | -0.35M | -21.73M |